146 related articles for article (PubMed ID: 9490674)
1. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis.
Bruno E; Horrigan SK; Van Den Berg D; Rozler E; Fitting PR; Moss ST; Westbrook C; Hoffman R
Blood; 1998 Mar; 91(6):1917-23. PubMed ID: 9490674
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Smad5 gene leads to enhanced proliferation of high-proliferative potential precursors during embryonic hematopoiesis.
Liu B; Sun Y; Jiang F; Zhang S; Wu Y; Lan Y; Yang X; Mao N
Blood; 2003 Jan; 101(1):124-33. PubMed ID: 12393578
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4.
Fuchs O; Simakova O; Klener P; Cmejlova J; Zivny J; Zavadil J; Stopka T
Blood Cells Mol Dis; 2002; 28(2):221-33. PubMed ID: 12064918
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit).
Heinrich MC; Dooley DC; Keeble WW
Blood; 1995 Apr; 85(7):1769-80. PubMed ID: 7535588
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
6. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation.
Morosetti R; Park DJ; Chumakov AM; Grillier I; Shiohara M; Gombart AF; Nakamaki T; Weinberg K; Koeffler HP
Blood; 1997 Oct; 90(7):2591-600. PubMed ID: 9326225
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
[TBL] [Abstract][Full Text] [Related]
8. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides.
Hatzfeld J; Li ML; Brown EL; Sookdeo H; Levesque JP; O'Toole T; Gurney C; Clark SC; Hatzfeld A
J Exp Med; 1991 Oct; 174(4):925-9. PubMed ID: 1717634
[TBL] [Abstract][Full Text] [Related]
9. Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.
Rosti V; Bergamaschi G; Lucotti C; Danova M; Carlo-Stella C; Locatelli F; Tonon L; Mazzini G; Cazzola M
Blood; 1995 Nov; 86(9):3387-93. PubMed ID: 7579442
[TBL] [Abstract][Full Text] [Related]
10. An antisense transcript to SMAD5 expressed in fetal and tumor tissues.
Zavadil J; Svoboda P; Liang H; Kottickal LV; Nagarajan L
Biochem Biophys Res Commun; 1999 Feb; 255(3):668-72. PubMed ID: 10049768
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1.
Sato T; Selleri C; Young NS; Maciejewski JP
Blood; 1995 Nov; 86(9):3373-80. PubMed ID: 7579440
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro.
Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
Blood; 1988 Nov; 72(5):1504-11. PubMed ID: 2460153
[TBL] [Abstract][Full Text] [Related]
13. Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta.
Ohishi K; Katayama N; Itoh R; Mahmud N; Miwa H; Kita K; Minami N; Shirakawa S; Lyman SD; Shiku H
Blood; 1996 Mar; 87(5):1718-27. PubMed ID: 8634417
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3.
Sato T; Selleri C; Young NS; Maciejewski JP
Blood; 1997 Dec; 90(12):4749-58. PubMed ID: 9389691
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia.
Jiang Y; Liang H; Guo W; Kottickal LV; Nagarajan L
Blood; 2000 Jun; 95(12):3945-50. PubMed ID: 10845932
[TBL] [Abstract][Full Text] [Related]
16. Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor beta 1 in normal and leukemic myeloid cells.
Lotem J; Sachs L
Blood; 1990 Oct; 76(7):1315-22. PubMed ID: 2207308
[TBL] [Abstract][Full Text] [Related]
17. tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression.
Zauli G; Davis BR; Re MC; Visani G; Furlini G; La Placa M
Blood; 1992 Dec; 80(12):3036-43. PubMed ID: 1281686
[TBL] [Abstract][Full Text] [Related]
18. Implication of a new molecule IK in CD34+ hematopoietic progenitor cell proliferation and differentiation.
Cao LX; Le Bousse-Kerdiles MC; Clay D; Oshevski S; Jasmin C; Krief P
Blood; 1997 May; 89(10):3615-23. PubMed ID: 9160666
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis.
Fogli M; Carlo-Stella C; Curti A; Ratta M; Tazzari PL; Ragazzi E; Colla S; Santucci AM; Tura S; Lemoli RM
Exp Hematol; 2000 Jul; 28(7):775-83. PubMed ID: 10907639
[TBL] [Abstract][Full Text] [Related]
20. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
Keller JR; Bartelmez SH; Sitnicka E; Ruscetti FW; Ortiz M; Gooya JM; Jacobsen SE
Blood; 1994 Oct; 84(7):2175-81. PubMed ID: 7919333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
